PFE Pfizer Inc
- Stocks
- Healthcare
- NYSE: PFE
Price (delayed)
$25.14
Market cap
$142.93B
P/E Ratio
13.3
Dividend/share
$1.71
EPS
$1.89
Enterprise value
$203.09B
Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United
Highlights
Pfizer's gross profit has increased by 41% YoY
The price to earnings (P/E) is 40% lower than the last 4 quarters average of 22.0 and 32% lower than the 5-year quarterly average of 19.5
The quick ratio has soared by 60% YoY but it has contracted by 16% from the previous quarter
Key stats
What are the main financial stats of PFE
Market
Valuations
Earnings
Shares outstanding
5.69B
Market cap
$142.93B
Enterprise value
$203.09B
Price to earnings (P/E)
13.3
Price to book (P/B)
1.61
Price to sales (P/S)
2.24
EV/EBIT
19.31
EV/EBITDA
11.74
EV/Sales
3.18
Revenue
$63.83B
Gross profit
$46.04B
Operating income
$10.54B
Net income
$10.75B
EBIT
$10.52B
EBITDA
$17.31B
Free cash flow
$12.44B
Per share
Balance sheet
Liquidity
EPS
$1.89
EPS diluted
$1.88
Free cash flow per share
$2.19
Book value per share
$15.6
Revenue per share
$11.23
TBVPS
$14.85
Total assets
$206.1B
Total liabilities
$117.08B
Debt
$61.8B
Equity
$88.7B
Working capital
$5.98B
Debt to equity
0.7
Current ratio
1.16
Quick ratio
0.67
Net debt/EBITDA
3.48
Margins
Efficiency
Dividend
EBITDA margin
27.1%
Gross margin
72.1%
Net margin
16.8%
Operating margin
16.5%
Return on assets
5.1%
Return on equity
12%
Return on invested capital
9.5%
Return on capital employed
6.2%
Return on sales
16.5%
Dividend yield
6.8%
DPS
$1.71
Payout ratio
90.5%
PFE stock price
How has the Pfizer stock price performed over time
Intraday
0.12%
1 week
2.28%
1 month
2.15%
1 year
-12.43%
YTD
-5.24%
QTD
3.71%
Financial performance
How have Pfizer's revenue and profit performed over time
Revenue
$63.83B
Gross profit
$46.04B
Operating income
$10.54B
Net income
$10.75B
Gross margin
72.1%
Net margin
16.8%
The operating income has grown by 43% from the previous quarter
Pfizer's gross profit has increased by 41% YoY
The company's operating margin rose by 40% QoQ
Pfizer's net income has increased by 36% QoQ
Price vs fundamentals
How does PFE's price correlate with its fundamentals
Growth
What is Pfizer's growth rate over time
Valuation
What is Pfizer stock price valuation
P/E
13.3
P/B
1.61
P/S
2.24
EV/EBIT
19.31
EV/EBITDA
11.74
EV/Sales
3.18
The price to earnings (P/E) is 40% lower than the last 4 quarters average of 22.0 and 32% lower than the 5-year quarterly average of 19.5
Pfizer's EPS has increased by 36% from the previous quarter
PFE's P/B is 36% below its 5-year quarterly average of 2.5 and 5% below its last 4 quarters average of 1.7
PFE's P/S is 30% below its 5-year quarterly average of 3.2 and 7% below its last 4 quarters average of 2.4
Pfizer's revenue has increased by 14% YoY and by 2.2% QoQ
Efficiency
How efficient is Pfizer business performance
The company's return on invested capital rose by 44% QoQ
Pfizer's ROS has increased by 40% from the previous quarter
Pfizer's ROA has increased by 38% from the previous quarter
The ROE rose by 36% QoQ
Dividends
What is PFE's dividend history
DPS
$1.71
Dividend yield
6.8%
Payout ratio
90.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Pfizer financials performed over time
PFE's total assets is 76% greater than its total liabilities
The quick ratio has soared by 60% YoY but it has contracted by 16% from the previous quarter
The current ratio has grown by 35% YoY but it has contracted by 8% from the previous quarter
PFE's debt is 30% less than its equity
The debt to equity has contracted by 11% YoY
PFE's debt is down by 11% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.